Twelves C, Sabel M, Checketts D, Miller S, et al. A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma. Br J Cancer 2021 Feb 24. pii: 10.1038/s41416-021-01259.
PMID: 33623076